EM Systems Co., Ltd.
Decision Financial Briefing Materials
FY2026.Q2 consolidated results are in the vicinity of 1 trillion yen in net sales, with both operating income and net income down YoY, but overall showing a recovery trend. Among segments, the pharmaceutical dispensing system remains the core growth driver. The outlook moving forward is under review to identify factors that may affect the full-year forecast.
Key Figures
- FY2026 Q2 Net sales 10,434 million yen
- FY2026 Q2 Operating income 922 million yen
- FY2026 Q2 Net income 663 million yen
AI要約
Section Heading
The earnings release explains the key points of FY2026.Q2 consolidated results, along with segment-specific状況 and future outlook. Net sales declined YoY, while the company is re-evaluating the business structure and assessing the impact of new initiatives. It details the segment composition and main drivers, and discusses factors that exerted pressure on profits this period.
Section 2 Heading
Shareholder return policy and dividend direction are expected to continue in line with the current strategy. Key factors include profitability improvement in the dispensing system business, ARPU trends, and profitability of medical-related businesses. The outlook will continue to be assessed for alignment with the full-year plan.
株式会社 EMシステムズ
Company overview · Stock price · Financial data · All IR
